Back to Browse Journals » International Journal of Nanomedicine » Volume 1 » Issue 4

Megestrol acetate in cachexia and anorexia

Authors Shing-Shing Yeh, Michael W Schuster

Published 15 January 2007 Volume 2006:1(4) Pages 411—416

Shing-Shing Yeh1, Michael W Schuster2

1Northport vAMC, Geriatric division, Northport, NY 11768; 2Weill Medical College of Cornell University and the New York Presbyterian Hospital, New York, NY 10021, USA

Abstract: The aim is to review major clinical trials that have used megestrol acetate (MA) in the treatment of cachexia across several disease states. A review of general usage and potential side-effects are discussed. A theory that the newly approved nanocrystal formation of MA can better deliver this potent medication for treatment will also be reviewed.

Keywords: megestrol acetate, nanocrystalline particles, cachexia

Download Article [PDF] 

Readers of this article also read:

Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells

Situ JQ, Ye YQ, Zhu XL, Yu RS, You J, Yuan H, Hu FQ, Du YZ

International Journal of Nanomedicine 2015, 10:665-675

Published Date: 17 January 2015

Management of refractory neonatal seizures

Neubauer D, Soltirovska-Salamon A, Osredkar D, Paro-Panjan D

Research and Reports in Neonatology 2014, 4:17-29

Published Date: 26 February 2014

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F

Biologics: Targets and Therapy 2013, 7:69-75

Published Date: 15 March 2013

Exploring the understanding of evidence-based concepts in people with type 2 diabetes

Hoffmann TC, Del Mar CB

International Journal of General Medicine 2012, 5:781-787

Published Date: 21 September 2012

Use of administrative hospital registry data and a civil registry to measure survival and other outcomes after cancer

Sørensen HT, Lash TL

Clinical Epidemiology 2011, 3:1-2

Published Date: 21 July 2011

Intravenous clevidipine for management of hypertension

Alma Rivera, Elsa Montoya, Joseph Varon

Integrated Blood Pressure Control 2010, 3:105-111

Published Date: 28 June 2010

The role of insulin detemir in overweight type 2 diabetes management

Yared N Demssie, Naveed Younis, Handrean Soran

Vascular Health and Risk Management 2009, 5:553-560

Published Date: 29 June 2009

Management of postoperative nausea and vomiting: focus on palonosetron

Neil A Muchatuta, Michael J Paech

Therapeutics and Clinical Risk Management 2009, 5:21-34

Published Date: 30 November 2008